直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

INCONTESTABLE® Blog

Court Reiterates That Standard for Recovering Attorney Fees Under Lanham Act Is High

December 1, 2017

Authored and Edited by Jonathan D. Uffelman; Naresh Kilaru; Julia Anne Matheson

On October 31, 2017, the Western District of Missouri denied a request for attorney fees that was based only on a successful defense against false advertising claims.

Plaintiff Healthmate International, LLC and Defendant Rampant Lion, Inc. sell Transcutaneous Electrical Nerve Stimulation (“TENS”) units, which use electrical currents to help relieve body pain.  In the course of litigation, Rampant Lion asserted a false advertising counterclaim based on a statement on Healthmate’s website describing some of its products as “FDA approved,” rather than “FDA cleared.”  Rampant Lion lost its false advertising claim, and Healthmate moved for attorney fees.

Healthmate argued the case was exceptional enough to warrant fee-shifting because Rampant Lion’s counterclaim was only a litigation tactic used to increase Healthmate’s cost of litigation.  As evidence, Healthmate pointed to the fact that Rampant Lion presented no evidence of customer confusion and unreasonably rejected Healthmate’s settlement offers.  The Court disagreed. 

According to the Court, Rampant Lion had a non-frivolous basis for its counterclaim because Healthmate’s statement that its products were “FDA approved” was inaccurate.  Further, Rampant Lion sought to overcome the lack of customer confusion evidence by contending Healthmate’s statement was literally false, which, under Eighth Circuit law, would have allowed the Court to grant relief without such evidence.  On summary judgment, the Court held that Healthmate’s statement was not literally false, and therefore to prevail, Rampant Lion had to present evidence of customer confusion.  The Court stated:  “The fact that the Court disagreed with Rampant Lion’s analysis does not make the case exceptional; to hold otherwise would make every case in which a party loses ‘exceptional’ and destroy the distinction between the Lanham Act’s fee provision and other fee-shifting provisions that merely require that a party prevail to recover fees.” 

The case is Healthmate International, LLC v. French, Case No. 15-0761-CV-W-BP (W.D. Mo. Oct. 31, 2017).

Tags

attorney fees, false advertising, Lanham Act

Related Practices

Trademark and Brand Management

Contacts

Jonathan D. Uffelman
Domain Name Specialist / Attorney
Washington, DC
+1 202 408 4328
Email
Naresh Kilaru
Partner
Washington, DC
+1 202 408 4236
Email

Copyright © 2017 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

Patent Litigation Europe 2027

January 18-20, 2027

Amsterdam

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Lecture

2026 Donald R. Dunner Endowed Lecture

October 27, 2026

Washington, DC

Seminar

Future IP UK

October 21, 2026

London

Conference

ChIPs Global Summit 2026

October 21-23, 2026

Los Angeles

Conference

LES 2026 Annual Meeting

October 18-21, 2026

San Diego

Conference

2026 FCBA Global Series Fall Session

October 14-16, 2026

Dublin

Conference

WTR Live: Brand Strategy Summit USA 2026

October 13-14, 2026

New York

Conference

LSX USA Congress 2026

September 23-24, 2026

Boston

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP